ARCHIVES

Studies Question PSA Screening: PLCO Trial Finds No Survival Advantage, European Trial Finds Benefit At High Cost

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | March 20, 2009

Download PDF Visit The Full Archive

Related Articles

Scripps, Sandoz Deal Becomes Case Study As NI Rethinks Sponsored Research

January 28, 1994

In Brief: Gift To St. Jude: $1 Million McDonald’s Ticket; Leitch Elected President, ACS Texas Division

January 5, 1996

Colorado Center Delays New Core Grant Application

July 13, 1979

New Toxicology Protocol Works, Predicts Safe starting Doses, Saves $1 Million

June 25, 1982

ACS Cancer Control Research Grant Programs Available

May 5, 2000

Samuel Waksal Pleads Guilty To Tax Evasion

March 7, 2003